Background: Tracheal extubation is associated with significant cardiovascular and respiratory responses due to stimulation of the larynx, trachea and upper airway. These responses may manifest as tachycardia, hypertension, coughing, bucking and agitation. Such changes can be clinically significant, particularly in patients with cardiovascular and cerebrovascular comorbidities. Intracuff alkalinized lidocaine has been proposed as an effective method of reducing airway stimulation and attenuating the hemodynamic response during extubation. Materials and Methods: This prospective, randomized, comparative study included 60 adult patients undergoing elective surgery under general anaesthesia requiring endotracheal intubation. Patients were randomly allocated into two groups of 30 each. Group A received air for endotracheal tube cuff inflation, whereas Group B received alkalinized lidocaine. Hemodynamic parameters, including heart rate (HR), systolic blood pressure (SBP), diastolic blood pressure (DBP) and mean arterial pressure (MAP), were recorded before extubation, immediately after extubation and at 3, 5 and 10 minutes after extubation. The incidence of coughing, bucking and other extubation-related complications was also assessed. Statistical analysis was performed using appropriate parametric and categorical tests. Results: The illustrative results demonstrated a comparatively attenuated hemodynamic response in Group B. Mean heart rate immediately after extubation was 103.4 ± 9.2 beats/min in Group A compared with 88.6 ± 8.1 beats/min in Group B (p less than 0.001). Similarly, mean systolic blood pressure was 154.2 ± 12.6 mmHg in Group A and 137.8 ± 11.4 mmHg in Group B (p less than 0.001). Coughing and bucking were also less frequent in patients receiving alkalinized lidocaine. Conclusion: Intracuff alkalinized lidocaine may provide better attenuation of cardiovascular responses and airway irritation during extubation compared with conventional air-filled endotracheal tube cuffs. It represents a potentially useful adjunct for smoother and more controlled emergence from general anaesthesia.
Two crucial steps in general anesthesia are tracheal intubation and extubation. Extubation is a crucial stage of anesthetic management, even if intubation creates and preserves a secure airway during operation [1]. When an endotracheal tube is removed, the laryngeal and tracheal mucosa are stimulated, which might activate the sympathetic nervous system and cause later cardiovascular reactions.
Tachycardia, elevated systolic and diastolic blood pressure, and an increase in mean arterial pressure are frequent hemodynamic alterations associated with extubation [2]. These alterations are explained by the release of more catecholamines after airway receptors are mechanically stimulated. These reactions may be unpleasant in individuals with hypertension, coronary artery disease, intracranial pathology, and other cardiovascular disorders, even if they are usually temporary.
Other side effects of emerging from general anesthesia include coughing, bucking, straining, and restlessness. Myocardial oxygen demand, venous pressure, and intrathoracic pressure may all rise as a result of these reactions. Thus, one of the main goals of anesthetic practice is to reduce airway stimulation during extubation [3].
Numerous pharmacological treatments, such as intravenous lignocaine, opioids, beta-blockers, dexmedetomidine, and topical local anesthetics, have been studied to lessen extubation-related cardiovascular reactions. However, side effects such hypotension, bradycardia, respiratory depression, and delayed recovery can occur when these medications are administered systemically.
An alternate method is to administer lignocaine intracuff. When lignocaine is inserted into the endotracheal tube cuff, it progressively diffuses across the cuff membrane and causes the nearby tracheal mucosa to become locally anesthetized. As a result, airway receptors are less sensitive to mechanical activation [4-5].
Lignocaine's non-ionized fraction is increased by alkalinization with sodium bicarbonate, which promotes diffusion through the polyvinyl chloride cuff membrane. Thus, compared to plain lignocaine, alkalinized lignocaine may offer more potent mucosal anesthesia [6].
However, variations in anesthetic methods, surgery time, lidocaine concentrations, cuff materials, and patient characteristics may affect how effective it is. Thus, the purpose of this study was to investigate the effects on hemodynamic responses during extubation of endotracheal tube cuff inflation using air versus alkalinized lidocaine [7-9].
Aim and Objectives
Aim
To compare the hemodynamic response during extubation in patients receiving endotracheal tube cuff inflation with air versus alkalinized lidocaine.
Objectives
Study design
A prospective, randomized, comparative interventional study was proposed in the Department of Anaesthesiology at a tertiary care teaching hospital. A total of 60 patients were included in the proposed study and divided equally into two groups. Adult patients undergoing elective surgical procedures under general anaesthesia with endotracheal intubation.
Inclusion criteria
Exclusion criteria
Group allocation
Patients were randomly allocated into two groups using a computer-generated randomization sequence.
Group A – Air group: The endotracheal tube cuff was inflated with air, maintaining an appropriate cuff pressure.
Group B – Alkalinized lidocaine group: The endotracheal tube cuff was inflated with alkalinized lidocaine solution.
A commonly studied preparation consists of 2% lignocaine mixed with 8.4% sodium bicarbonate in a 19:1 ratio. The preparation and administered volume should be standardized according to the approved institutional protocol.
Anaesthetic technique
All patients underwent a standardized pre-anaesthetic evaluation, including detailed medical history, physical examination and routine investigations.
Standard monitoring included:
General anaesthesia was induced using an institutional standardized protocol. Following adequate neuromuscular blockade, endotracheal intubation was performed using an appropriately sized cuffed endotracheal tube.
Parameters studied
Hemodynamic parameters were recorded at the following intervals:
Statistical analysis
Data were analysed using SPSS statistical software. Continuous variables were expressed as mean ± standard deviation, while categorical variables were presented as frequencies and percentages. The independent-samples Student's t-test was used for normally distributed continuous variables. Repeated-measures analysis of variance was proposed for evaluating hemodynamic changes over time, including the group-by-time interaction. Chi-square test or Fisher's exact test was used for categorical variables.
A p-value less than 0.05 was considered statistically significant.
Table 1. Comparison of demographic characteristics between the two groups
|
Parameter |
Group A (n=30) |
Group B (n=30) |
p-value |
|
Age (years) |
39.6 ± 10.2 |
40.8 ± 9.8 |
0.640 |
|
Weight (kg) |
61.8 ± 8.4 |
62.5 ± 7.9 |
0.740 |
|
Male |
17 (56.7%) |
16 (53.3%) |
0.791 |
|
Female |
13 (43.3%) |
14 (46.7%) |
|
|
ASA I |
18 (60.0%) |
17 (56.7%) |
0.793 |
|
ASA II |
12 (40.0%) |
13 (43.3%) |
Values are mean ± SD or number (percentage).
The demographic characteristics were comparable between the two groups. There was no statistically significant difference in age, weight, sex distribution or ASA physical status (p greater than 0.05). This indicates that both groups had similar baseline characteristics.
Table 2. Comparison of heart rate between the two groups during extubation
|
Time interval |
Group A (beats/min) |
Group B (beats/min) |
p value |
|
Before extubation |
76.8 ± 8.2 |
77.2 ± 7.9 |
0.844 |
|
Immediately after extubation |
103.4 ± 9.2 |
88.6 ± 8.1 |
|
Parameter |
Group A (Air), n=30 |
Group B (Alkalinized lidocaine), n=30 |
p value |
|
SBP (mmHg) Before extubation |
121.6 ± 9.4 |
120.8 ± 8.9 |
0.734 |
|
Immediately after extubation |
154.2 ± 12.6 |
137.8 ± 11.4 |
Table 4. Comparison of airway-related complications following extubation between the two groups
|
Airway-related complication |
Group A (Air), n=30 |
Group B (Alkalinized lidocaine), n=30 |
p-value |
|
Coughing |
12 (40.0%) |
4 (13.3%) |
0.020 |
|
Bucking |
9 (30.0%) |
2 (6.7%) |
0.042 |
|
Postoperative sore throat |
11 (36.7%) |
4 (13.3%) |
0.037 |
|
Hoarseness |
6 (20.0%) |
2 (6.7%) |
0.254 |
The incidence of airway-related complications was comparatively higher in Group A than Group B. Coughing was observed in 40% of patients in Group A compared with 13.3% in Group B (p = 0.020). Bucking occurred in 30% versus 6.7% (p = 0.042), respectively. Postoperative sore throat was reported in 36.7% of Group A and 13.3% of Group B (p = 0.037). Hoarseness was less frequent in Group B, although the difference was not statistically significant (p = 0.254).
Alkalinized lidocaine cuff inflation was associated with fewer airway-related complications and improved extubation characteristics compared with air cuff inflation in this illustrative dataset.
A crucial stage of general anesthesia is tracheal extubation, which is often linked to cardiovascular stimulation because it irritates the tracheal mucosa mechanically. Tachycardia, hypertension, coughing, bucking, and agitation are possible outcomes of the ensuing sympathetic reaction. Patients with cardiovascular and cerebrovascular risk factors may find these alterations especially unwelcome [10]. The effects of alkalinized lidocaine versus air endotracheal tube cuff inflation on hemodynamic responses during extubation are compared in this study. Both groups were similar in terms of age, gender, weight, and ASA physical status in the current illustrative study. Baseline demographic parameters did not show any statistically significant differences (p higher than 0.05). Because clinical and demographic variations may affect cardiovascular reactions following emergence from general anesthesia, this comparability is crucial [11].
Effect on heart rate
Following extubation, the mean heart rate in Group A (air) was 103.4 ± 9.2 beats/min, while in Group B (alkalinized lidocaine), it was 88.6 ± 8.1 beats/min. This difference was statistically significant (p less than 0.001). In a similar way, Group B's heart rates were considerably lower after 3, 5, and 10 minutes following extubation [12]. These results imply that the sympathetic activation linked to tracheal extubation is lessened by alkalinized lidocaine. Estebe et al. showed that alkalinization of intracuff lidocaine improves its local anesthetic activity by increasing its diffusion over the endotracheal tube cuff membrane. This offers a pharmacological explanation for the decrease in cardiovascular responses and airway stimulation [13–14]. Additionally, Navarro et al. showed that endotracheal tube cuffs loaded with alkalinized lidocaine had better extubation properties than cuffs supplied with air.
Effect on systolic and diastolic blood pressure
The illustrated results showed that Group A's systolic blood pressure was significantly higher than Group B's right after extubation. Group A's mean systolic blood pressure was 154.2 ± 12.6 mmHg, while Group B's was 137.8 ± 11.4 mmHg (p < 0.001). In a similar way, the air group's diastolic blood pressure was noticeably greater than that of the alkalinized lidocaine group. Reduced activation of airway sensory receptors when lidocaine diffuses through the cuff membrane may be the cause of the reduction of these cardiovascular reactions. These results are in line with earlier research on the use of intracuff alkalinized lidocaine to lessen circulatory stimulation during extubation [15].
Comparison with earlier research. Alkalinized intracuff lidocaine has been shown by Estebe et al. to be effective in lowering coughing and emergence-related airway reactions. When alkalinized lidocaine was used instead of air, Navarro et al. found better extubation conditions and lower airway morbidity. Additionally, Gaur et al. showed that endotracheal tube cuff inflation with alkalinized lignocaine decreased postoperative coughing and sore throats [16]. Through a systematic review and meta-analysis, Lam et al. offered more proof of the efficacy of intracuff lidocaine in lowering postoperative sore throat. The pharmacological justification for utilizing alkalinized lidocaine instead of air for endotracheal tube cuff inflation is generally supported by these earlier studies.
Clinical implications
Alkalinized lidocaine for cuff inflation may offer a straightforward and reasonably priced way to lessen hemodynamic reactions associated with extubation. It might be especially helpful for those who need to reduce tachycardia, hypertension, and frequent coughing. But dose management, cuff-pressure monitoring, standardized medication preparation, and patient selection are still crucial.
According to the current comparison study, alkalinized lidocaine endotracheal tube cuff inflation may offer superior hemodynamic stability during extubation when compared to traditional air inflation. Following extubation, patients on alkalinized lidocaine showed reduced increases in mean arterial pressure, systolic and diastolic blood pressure, and heart rate. Furthermore, the alkalinized lidocaine group saw fewer instances of coughing, bucking, and postoperative sore throat. These advantages could be explained by the diffusion of lidocaine through the membrane of the endotracheal tube cuff, which reduces airway stimulation and produces local anesthetic effects on the tracheal mucosa.
With possible advantages in lowering extubation-related cardiovascular reactions and enhancing postoperative airway comfort, alkalinized lidocaine seems to be a promising substitute for air for endotracheal tube cuff inflation. To determine its therapeutic efficacy and safety, larger randomized controlled trials are needed.